"超越三重疗法:杜皮卢马布是COPD治疗2型炎症的经济有效选择吗?"
Jefferson Antonio Buendía1, Luisa Fernanda Manrique Acevedo2, Carlos Celis Preciado3
1Research Group in Pharmacology and Toxicology. Department of Pharmacology and Toxicology. University of Antioquia, Medellín, Colombia.
Respiratory medicine
|July 16, 2025
概括
在哥伦比亚,以目前的价格,杜皮卢马布对埃索诺菲尔性慢性肺炎的治疗不具有成本效益. 显著降低药物成本是必要的,因为它被认为是患者可行的治疗选择.
科学领域:
- 肺部医学 肺部医学
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
背景情况:
- 慢性阻塞性肺病 (COPD) 构成了全球严重的健康负担.
- 一个特定的2型炎症患者群体和高氨基细胞经历了频繁的恶化,尽管最佳的吸入疗法.
- 杜皮卢马布在这个子组中表现出有效性,但它的成本效益,特别是在中等收入国家,需要进行彻底的评估.
研究的目的:
- 评估dupilumab在哥伦比亚治疗中度至非常严重的乙性慢性肺炎的成本效益.
- 从哥伦比亚卫生系统的角度来看,比较dupilumab与标准护理的成本效益.
主要方法:
- 一个终身地平线马尔科夫模型模拟了每月周期的COPD进展.
- 临床疗效数据来自BOREAS和NOTUS试验.
- 成本和公用事业数据基于哥伦比亚的来源,更新到2024美元,5%的折扣率和5180美元/QALY的门.
主要成果:
- 杜皮卢马布以31,072美元的额外成本提供了额外的2.41个QALY,导致增量成本效益比 (ICER) 为12,905美元/QALY,超过了哥伦比亚的门.
- 净货币收益有利于标准护理,而不是dupilumab.
- 敏感性分析表明,只有当每月药物成本低于238美元时,才能实现成本效益;概率性敏感性分析显示,dupilumab在100%的代中没有成本效益.
结论:
- 目前杜皮卢马布的定价使得它在哥伦比亚的异敏性慢性肺炎中不具有成本效益.
- 可持续的采用需要大幅降低价格或实施创新的支付模式,例如基于结果的协议.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
319
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
319
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:17Drugs Used in Lower Respiratory Disorders: Overview
599
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
599
01:20COPD: Pathogenesis and Clinical Features
531
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
531